The Global Implantable Cardioverter-Defibrillator Market size is expected to grow from $4,814.0 million in 2020 to $5,496.0 million by 2028 with a compound annual growth rate (CAGR) of 2.0% during the forecast period. The major factors driving this market are the increasing incidence of sudden cardiac death and heart failure due to the aging population along with advances in technology that allow for more accurate detection of irregular heart rhythm patterns which can lead to arrhythmias such as atrial fibrillation and ventricular tachycardia.
An Implantable Cardioverter-Defibrillator is also known as ICD or CRT-D is a medical device that's surgically implanted under the skin to treat life-threatening cardiac arrhythmias. The device monitors and treats abnormal heart rhythms by pacing (a series of low voltage electrical impulses), delivering high voltage shocks through electrodes on the leads, or both.
AICDs have been shown to reduce rates of death from sudden cardiac arrest in patients with certain types of ventricular tachycardia such as post-infarction cardiomyopathy and LQTS type II more than people without an AICD do.
On the basis of Types, the market is segmented into Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), and Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS) is a device that delivers an electric shock to the heart in order to prevent sudden cardiac death. Patients with S-ICD have their own primary care physician who will determine when and if they need shocks, as well as how many are needed for each episode of tachycardia or ventricular fibrillation.
Transvenous Implantable Cardioverter-Defibrillator (T-ICDs) can be defined as an implantable device that is surgically implanted under the skin, usually in a major vein near the heart. They are used to treat and prevent sudden cardiac arrest (SCA) by defibrillating or pacing when necessary. The T-ICDs have a lead wire with electrodes at its end which is inserted through an opening in the groin into one of four chambers of the heart.
The CRT-D is a device that synchronizes the heart's electrical impulses to help prevent sudden cardiac arrest and rhythm disturbance. The device can also reduce symptoms of congestive heart failure, including shortness of breath or ankle swelling.
On the basis of Application, the market is segmented into Hospitals and Clinics. An Implantable Cardioverter-Defibrillator can be used in hospitals as a device that is implanted inside the chest to monitor and correct an arrhythmia. It monitors heart rhythms, knows when to deliver pulses of electric energy to restore normal rhythm or a shock if necessary. The battery has typically lasted years without needing replacement and it allows for patients who are otherwise at risk from sudden death due to abnormal heartbeat rhythms (i.e., ventricular tachycardia) because medications have not been working well enough.
On the basis of Region, the market is segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. The North American market for implantable cardioverter defibrillators (ICDs) is projected to grow at a faster pace. The key factors that are driving this growth are the increasing number of cardiac events, increasing prevalence of cardiovascular diseases, and improved reimbursement scenario in developed economies such as Canada and Mexico.
The European market is projected to grow significantly. This growth can be attributed to the rapidly aging population who are susceptible to heart disease or frequent arrhythmias which will require long-term therapy through implanted devices.
The Asia Pacific is also expected to register robust growth due mainly to rising in living standards leading people towards high-risk lifestyle changes like eating habits, tobacco use, or sedentary lifestyle which are the major driving factors for chronic diseases such as cardiac problems.
MENA region has been witnessing a surge in demand from key countries namely Saudi Arabia, Egypt, and Israel among others due to favorable policy initiatives along with increasing awareness on benefits these devices provide leading them to become the preferred treatment option available for patients suffering from cardiovascular conditions.
Latin America too will account for significant gains during the forecast period owing mainly to a due increase in the prevalence of chronic diseases like hypertension and diabetes.
Up Market Research published a new report titled “Implantable Cardioverter Defibrillator Market research report which is segmented by Types (Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Cardiac Resynchronization Therapy Defibrillator (CRT-D)), By Applications (ASCs, Hospital, Clinic), By Players/Companies ZOLL Medical Corporation (US), Boston Scientific Corporation (US), BIOTRONIK SE & Co. KG (Germany), Medtronic PLC (Ireland), Abbott, Koninklijke Philips N.V. (Netherlands), Medtronic Plc, PHILIPS HEALTHCARE, Sorin Group, Nihon Kohden Corporation”.
|Report Attributes||Report Details|
|Report Title||Implantable Cardioverter Defibrillator Market Research Report|
|By Type||Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Cardiac Resynchronization Therapy Defibrillator (CRT-D)|
|By Application||ASCs, Hospital, Clinic|
|By Companies||ZOLL Medical Corporation (US), Boston Scientific Corporation (US), BIOTRONIK SE & Co. KG (Germany), Medtronic PLC (Ireland), Abbott, Koninklijke Philips N.V. (Netherlands), Medtronic Plc, PHILIPS HEALTHCARE, Sorin Group, Nihon Kohden Corporation|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||235|
|Number of Tables & Figures||165|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Cardiac Resynchronization Therapy Defibrillator (CRT-D) and By Application ASCs, Hospital, Clinic.
Some of the companies that are profiled in this report are:
Implantable Cardioverter Defibrillator Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Implantable Cardioverter Defibrillator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Implantable Cardioverter Defibrillator Market Report:
Some other reports from this category!